Table for the 2 triples with object "The FDA notes that this is a "weak" CYP2C8 inhibitor in vivo in it most recent guidance document. See Table 6, p23" sorted by label

SubjectPredicate
?:evidence_1353?:content
?:evidence_1913?:content